Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan
· Delayed Price · Currency is TWD 152.00
-0.50 (-0.33%)
Apr 29, 2026, 12:48 PM CST
Alar Pharmaceuticals Revenue
In the year 2025, Alar Pharmaceuticals had annual revenue of 2.75M TWD, down -52.67%. Alar Pharmaceuticals had revenue of 1.50M in the quarter ending December 31, 2025.
Revenue
2.75M
Revenue Growth
-52.67%
P/S Ratio
3,700.33
Revenue / Employee
n/a
Employees
27
Market Cap
10.19B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Standard Chemical & Pharmaceutical | 7.02B |
| Foresee Pharmaceuticals | 431.27M |
| Handa Pharmaceuticals | 1.73B |
| YungShin Global Holding | 8.38B |
| Synmosa Biopharma | 6.19B |
| ScinoPharm Taiwan | 3.16B |
| Formosa Laboratories | 4.85B |
| Grape King Bio | 10.25B |